Healthcare & Life Sciences

APTARION BIOTECH AG

Germany

seed

Stage

Investors

About

Develops engineered heart tissue derived from stem cells, creating a "heart patch" designed to repair or regenerate damaged cardiac tissue for cardiology applications.

Explore APTARION BIOTECH AG's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.